» Articles » PMID: 29863285

RNA Sequencing Confirms Similarities Between PPI-responsive Oesophageal Eosinophilia and Eosinophilic Oesophagitis

Overview
Date 2018 Jun 5
PMID 29863285
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Although current American guidelines distinguish proton pump inhibitor-responsive oesophageal eosinophilia (PPI-REE) from eosinophilic oesophagitis (EoE), these entities are broadly similar. While two microarray studies showed that they have similar transcriptomes, more extensive RNA sequencing studies have not been done previously.

Aim: To determine whether RNA sequencing identifies genetic markers distinguishing PPI-REE from EoE.

Methods: We retrospectively examined 13 PPI-REE and 14 EoE biopsies, matched for tissue eosinophil content, and 14 normal controls. Patients and controls were not PPI-treated at the time of biopsy. We did RNA sequencing on formalin-fixed, paraffin-embedded tissue, with differential expression confirmation by quantitative polymerase chain reaction (PCR). We validated the use of formalin-fixed, paraffin-embedded vs RNAlater-preserved tissue, and compared our formalin-fixed, paraffin-embedded EoE results to a prior EoE study.

Results: By RNA sequencing, no genes were differentially expressed between the EoE and PPI-REE groups at the false discovery rate (FDR) ≤0.01 level. Compared to normal controls, 1996 genes were differentially expressed in the PPI-REE group and 1306 genes in the EoE group. By less stringent criteria, only MAPK8IP2 was differentially expressed between PPI-REE and EoE (FDR = 0.029, 2.2-fold less in EoE than in PPI-REE), with similar results by PCR. KCNJ2, which was differentially expressed in a prior study, was similar in the EoE and PPI-REE groups by both RNA sequencing and real-time PCR.

Conclusion: Eosinophilic oesophagitis and PPI-REE have comparable transcriptomes, confirming that they are part of the same disease continuum.

Citing Articles

A synthesis and subgroup analysis of the eosinophilic esophagitis tissue transcriptome.

Jacobse J, Brown R, Revetta F, Vaezi M, Buendia M, Williams C J Allergy Clin Immunol. 2023; 153(3):759-771.

PMID: 37852329 PMC: 10939980. DOI: 10.1016/j.jaci.2023.10.002.


Recent Advances in the Treatment of Eosinophilic Esophagitis.

Uchida A, Burk C, Rothenberg M, Furuta G, Spergel J J Allergy Clin Immunol Pract. 2023; 11(9):2654-2663.

PMID: 37391018 PMC: 10530275. DOI: 10.1016/j.jaip.2023.06.035.


Models and Tools for Investigating Eosinophilic Esophagitis at the Bench.

Uchida A, Ro G, Garber J, Peterson K, Round J Front Immunol. 2022; 13:943518.

PMID: 35874718 PMC: 9296852. DOI: 10.3389/fimmu.2022.943518.


Proton Pump Inhibitor Therapy for Eosinophilic Esophagitis: History, Mechanisms, Efficacy, and Future Directions.

Franciosi J, Mougey E, Dellon E, Gutierrez-Junquera C, Fernandez-Fernandez S, Venkatesh R J Asthma Allergy. 2022; 15:281-302.

PMID: 35250281 PMC: 8892718. DOI: 10.2147/JAA.S274524.


Pulmonary Eosinophilic Granulomatosis with Polyangiitis Has IgG4 Plasma Cells and Immunoregulatory Features.

Dong Z, Lin E, Wechsler M, Weller P, Klion A, Bochner B Am J Pathol. 2020; 190(7):1438-1448.

PMID: 32251643 PMC: 7322366. DOI: 10.1016/j.ajpath.2020.03.005.


References
1.
Liacouras C, Furuta G, Hirano I, Atkins D, Attwood S, Bonis P . Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011; 128(1):3-20.e6. DOI: 10.1016/j.jaci.2011.02.040. View

2.
Sayej W, Patel R, Baker R, Tron E, Baker S . Treatment with high-dose proton pump inhibitors helps distinguish eosinophilic esophagitis from noneosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2009; 49(4):393-9. DOI: 10.1097/MPG.0b013e31819c4b3e. View

3.
Gutierrez-Junquera C, Fernandez-Fernandez S, Cilleruelo M, Rayo A, Echeverria L, Quevedo S . High Prevalence of Response to Proton-pump Inhibitor Treatment in Children With Esophageal Eosinophilia. J Pediatr Gastroenterol Nutr. 2015; 62(5):704-10. DOI: 10.1097/MPG.0000000000001019. View

4.
Zhang X, Cheng E, Huo X, Yu C, Zhang Q, Pham T . Omeprazole blocks STAT6 binding to the eotaxin-3 promoter in eosinophilic esophagitis cells. PLoS One. 2012; 7(11):e50037. PMC: 3503709. DOI: 10.1371/journal.pone.0050037. View

5.
Li B, Dewey C . RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics. 2011; 12:323. PMC: 3163565. DOI: 10.1186/1471-2105-12-323. View